Comparing anticoagulants for platelet function analysis in hemostasis
Official title: Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
Run by Centre Hospitalier Universitaire Dijon · NCT06753838 · Data updated 2026-11-12
This study is testing whether a new type of blood collection tube can give better results for patients with bleeding disorders compared to the standard tube used for checking how well blood clots.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Status | Recruiting |
| Started | January 21, 2025 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT06753838 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults receiving hemostasis consultations who are undergoing a prescribed PFA test.
✕Probably not a fit
Patients who are under legal protection, pregnant, or unable to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of different anticoagulants in platelet function analysis, specifically comparing conventional citrate tubes with BAPA tubes. The PFA test will be performed on patients receiving hemostasis consultations at a specialized treatment center, where blood samples will be collected using both types of tubes. The goal is to determine if the BAPA tube, which uses a different mechanism to block coagulation, yields more reliable results with less technical difficulty. This could enhance the understanding of primary hemostasis and improve patient care in bleeding disorders.
Why it matters
Potential benefit: If successful, this study could lead to more accurate assessments of platelet function, improving diagnosis and treatment for patients with bleeding disorders.
How similar studies have gone: While this approach is relatively novel, previous studies have indicated the importance of anticoagulant choice in platelet function testing, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person having given their non-opposition * Person of legal age * Person receiving a haemostasis consultation at the haemophilia and haemorrhagic diseases treatment center followed by a blood sample with a PFA test prescribed by the doctor (the test is not added for the study). Exclusion Criteria: * persons under legal protection (curatorship, guardianship) * persons subject to a court protection order * pregnant, parturient or breast-feeding women * adult incapable or unable to give consent * minor
Where it's running
-
CHU Dijon Bourgogne
Dijon, France Recruiting
Study contacts
- Study coordinator: Emmanuel De Maistre
- Email: emmanuel.demaistre@chu-dijon.fr
- Phone: 03 80 29 32 57
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NasoAid vs NasoPore after Nasal Surgery
This study tests whether collagen-based NasoAid® nasal packing works as well as the synthetic NasoPore for stopping bleeding after nasal surgery in adults.
-
Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax
This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.
-
Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery
This study tests how well surgeons’ choices about topical hemostatic agents match current guidelines in cardiac and vascular surgery at one Milan hospital.
-
Topical tranexamic acid to cut blood loss during cesarean delivery
This study tests whether spraying tranexamic acid onto the uterine incision during cesarean delivery can reduce bleeding compared with placebo.
-
Ultrasound of the Spleen at Diagnostic Levels to See if Platelet Activity Changes
This study tests whether low-energy ultrasound focused on the spleen can alter blood clotting markers in healthy adults aged 18–50.
-
Analyzing blood clotting in hospitalized COVID-19 patients with severe pneumonia
This study looks at how COVID-19 affects blood clotting in hospitalized patients with severe pneumonia to see if it can help improve their treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.